Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Macrilen for diagnosis of adult growth hormone deficiency

Dec. 21, 2017

REGENXBIO's IND for study of RGX-121 in MPS II now active

Dec. 20, 2017

Shire reports topline results from phase II/III study of SHP-609

Dec. 20, 2017

KalVista Pharmaceuticals identifies novel plasma kallikrein inhibitors

Dec. 19, 2017

Ultragenyx Pharmaceutical sells Rare Pediatric Disease Priority Review Voucher to Novartis

Dec. 19, 2017

Orchard Therapeutics contracts Yposkesi for lentiviral vector batches

Dec. 19, 2017

European MAA for patisiran submitted by Sanofi and Alynylam

Dec. 19, 2017

Phase II trial of LJPC-401 in hereditary hemochromatosis begins

Dec. 19, 2017

EMA committee recommends approval of Alkindi for pediatric adrenal insufficiency

Dec. 18, 2017

EMA committee recommends approval of Ozempic for type 2 diabetes

Dec. 18, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...